Home > Publications > Peer-reviewed publications

Peer-reviewed Publications

Alassiri, A., Ali, R., Shen, Y., Lum, A., Strahlendorf, C., Deyell, R., et al. Ng, T. (2016, 8 1). Etv6-ntrk3 Is Expressed in a Subset of Alk-negative Inflammatory Myofibroblastic Tumors. The American Journal of Surgical Pathology, 40(8), 1051-1061.

Bose, P., Pleasance, E. D., Jones, M., Shen, Y., Ch'ng, C., Reisle, C., et al. Jones, S. J. (2015). Integrative genomic analysis of ghost cell odontogenic carcinoma. Oral Oncology, 51(9), e71-e75. doi:10.1016/J.ORALONCOLOGY.2015.06.013

Chooback, N., Shen, Y., Jones, M., Kasaian, K., Martin, M., Ng, T., et al. Ho, C. (2017, 6 28). Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy. Current Oncology, 24(3), 251.

Chow-White, P., Ha, D., & Laskin, J. (2017). Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists. Human Resources for Health.

Jamshidi, F., Pleasance, E., Li, Y., Shen, Y., Kasaian, K., Corbett, R., et al. Yip, S. (2014, 6). Diagnostic value of next-generation sequencing in an unusual sphenoid tumor. The oncologist, 19(6), 623-30.

Jones, M., Lim, H., Shen, Y., Pleasance, E., Ch'ng, C., Reisle, C., et al. Laskin, J. (n.d.). Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer. Annals of Oncology.

Jones, M., Schrader, K., Shen, Y., Pleasance, E., Ch'ng, C., Dar, N., et al. Lim, H. (2016, 5 1). Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer. Annals of Oncology, 27(5), 801-806.

Laskin, J., Ha, D., Chan, T., Fok, A., Gelmon, K., Charters, A., et al. Chow-White, P. (2016, 10 1). Clinicians identify high need to increase their genomic literacy to applied cancer genomics. Annals of Oncology, 27(suppl_6).

Laskin, J., Jones, S., Aparicio, S., Chia, S., Ch'ng, C., Deyell, R., et al. Marra, M. (2015, 10 1). Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers. Cold Spring Harbor molecular case studies, 1(1), a000570.

Parker, J., Shen, Y., Pleasance, E., Li, Y., Schein, J., Zhao, Y., et al. Karsan, A. (2016, 3). Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing. Cold Spring Harbor molecular case studies, 2(2), a000679.

Sheffield, B., Fulton, R., Kalloger, S., Milne, K., Geller, G., Jones, M., et al. Ionescu, D. (2016, 10 2). Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non–small Cell Lung Cancer. Journal of Histochemistry & Cytochemistry, 64(10), 587-600.

Sheffield, B., Tessier-Cloutier, B., Li-Chang, H., Shen, Y., Pleasance, E., Kasaian, K., et al. Schaeffer, D. (2016, 12 22). Personalized oncogenomics in the management of gastrointestinal carcinomas— early experiences from a pilot study. Current Oncology, 23(6), 571.

Sheffield, B., Tinker, A., Shen, Y., Hwang, H., Li-Chang, H., Pleasance, E., et al. Marra, M. (2015, 3 23). Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing. (S. Deb, Ed.) PLOS ONE, 10(3), e0119689.

Thibodeau, M. L., Reisle, C., Zhao, E., Martin, L. A., Alwelaie, Y., Mungall, K. L., et al. Jones, S. J. (2017, 9 16). Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma. Cold Springs Harbour Molecular Case Studies, 3(5), mcs.a001628. doi:10.1101/mcs.a001628

Weymann, D., Laskin, J., Roscoe, R., Schrader, K., Chia, S., Yip, S., et al. Regier, D. (2017, 5 1). The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers. Molecular Genetics & Genomic Medicine, 5(3), 251-260.